O'Reilly Auto Parts and The CW moving away from development series branding with a new TV commercial and tagline.
The trio, who all starred in Bud Light's 2025 Big Game commercial, are back for the 60-second Super Bowl 2026 ad ...
AbbVie ABBV has built a substantial neuroscience franchise. While the segment was initially anchored by Botox Therapeutic and the depression drug Vraylar, its offerings now include the oral migraine ...
With a slower economy and higher unemployment, construction took a hit in 2025. Experts and research firms forecast a year of stabilization and recovery for commercial real estate in 2026. Here's what ...
AbbVie's guidance for the next few years implies robust revenue growth. Some of the company's products are performing even better than expected. AbbVie's valuation and dividend program seal the deal.
Nike released a new Caitlin Clark commercial on Christmas Day, ahead of her 2026 CC Signature collection launch. Clark, a former Iowa women's basketball star, is asked throughout the commercial if she ...
Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from ...
Commercial real estate has had a rough go after gaining momentum coming out of the pandemic. October was the first month of negative year-over-year transaction volume growth in the sector in nearly ...
Poor commercial real estate. Fewer investors want to touch it after being burned by falling property values in recent years. They have better options anyway. Why settle for 7% annual returns on real ...
The following content is brought to you by Mashable partners. If you buy a product featured here, we may earn an affiliate commission or other compensation. TL;DR: Free office apps only go so far — ...
The US government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs Ozempic and Wegovy for Medicare patients. Medicare plans already get ...
Vraylar (cariprazine) is a powerful antipsychotic medication that is approved by the Food and Drug Administration (FDA) to treat schizophrenia, bipolar disorder, and major depressive disorder (MDD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results